Myelodysplastic syndromes: a review for nurses

Area of Science:

• Hematology
• Oncology Nursing

Background:

• Myelodysplastic Syndromes (MDS) are clonal stem cell disorders.
• MDS presents similarly to hematologic malignancies but requires distinct treatment approaches.
• Treatment varies from supportive care to advanced therapies like immunotherapy.

Purpose of the Study:

• To highlight the unique nature of Myelodysplastic Syndromes (MDS).
• To emphasize the critical role of oncology nurses in managing MDS.
• To outline key nursing interventions for MDS patients and their families.

Main Methods:

• Review of the pathophysiology of Myelodysplastic Syndromes.
• Analysis of current treatment modalities for MDS.
• Identification of essential nursing roles in MDS care.

Main Results:

• MDS originates from a clonal disorder of bone marrow stem cells.
• Treatment decisions for MDS are primarily based on disease severity.
• Oncology nurses are well-positioned to provide comprehensive care for MDS.

Conclusions:

• Effective nursing interventions for MDS include patient and family education.
• Emotional support and symptom management are crucial components of nursing care for MDS.
• A strong understanding of MDS pathophysiology enables nurses to optimize patient outcomes.